Literature DB >> 8862594

Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones.

T Deguchi1, M Yasuda, M Nakano, S Ozeki, T Ezaki, S Maeda, I Saito, Y Kawada.   

Abstract

Mutations in the gyrA gene resulting in amino acid changes at Ser-91 and Asp-95 are significantly associated with decreased susceptibilities to quinolones in Neisseria gonorrhoeae. To detect these mutations, we developed a rapid and simple assay based on amplification of the region of the gyrA gene containing the mutation sites by PCR and digestion of the PCR product with a restriction enzyme. A naturally occurring HinfI restriction site was present in the region containing the Ser-91 codon, and an artificial HinfI restriction site was created in the region containing the Asp-95 codon by the method of primer-specified restriction site modification. The mutations generating alterations at Ser-91 and Asp-95 were detected as restriction fragment length polymorphisms of the PCR products digested with HinfI. Fifty-five clinical strains of N. gonorrhoeae were examined for mutations in the gyrA gene by this method. Mutations at Ser-91 and/or Asp-95 were detected in all the 31 strains in which the mutations had been confirmed by DNA sequencing. Our method allows simultaneous testing of a large number of strains and provides results within 8 h. This rapid and simple assay could be a useful screening device for genetic alterations associated with decreased susceptibilities to quinolones in N. gonorrhoeae and could facilitate epidemiological studies on clinical isolates of N. gonorrhoeae with decreased susceptibilities to quinolones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862594      PMCID: PMC229227          DOI: 10.1128/jcm.34.9.2255-2258.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea.

Authors:  J W Tapsall; T R Shultz; R Lovett; R Munro
Journal:  Med J Aust       Date:  1992-01-20       Impact factor: 7.738

2.  Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.

Authors:  J E Corkill; A Percival; M Lind
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

Review 3.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.

Authors:  K Hayashi
Journal:  PCR Methods Appl       Date:  1991-08

Review 4.  Fluoroquinolone antimicrobial agents.

Authors:  D C Hooper; J S Wolfson
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

5.  Ciprofloxacin resistance in gonococci.

Authors:  A E Jephcott; A Turner
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

6.  Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  W R Gransden; C A Warren; I Phillips; M Hodges; D Barlow
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

7.  Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  S Sreedharan; L R Peterson; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

8.  DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.

Authors:  S Sreedharan; M Oram; B Jensen; L R Peterson; L M Fisher
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

9.  Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

Authors:  D C Stein; R J Danaher; T M Cook
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

10.  Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.

Authors:  Y Wang; W M Huang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

View more
  9 in total

1.  Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.

Authors:  U Chaudhry; K Ray; M Bala; D Saluja
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

2.  Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.

Authors:  S Ozeki; T Deguchi; M Yasuda; M Nakano; T Kawamura; Y Nishino; Y Kawada
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Use of applied biosystems 7900HT sequence detection system and Taqman assay for detection of quinolone-resistant Neisseria gonorrhoeae.

Authors:  Julie Giles; Justin Hardick; Jeffrey Yuenger; Michael Dan; Karl Reich; Jonathan Zenilman
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.

Authors:  I Lysnyansky; I Mikula; I Gerchman; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

5.  Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.

Authors:  D L Trees; A L Sandul; W L Whittington; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

6.  Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones.

Authors:  T Deguchi; M Yasuda; M Nakano; E Kanematsu; S Ozeki; Y Nishino; T Ezaki; S Maeda; I Saito; Y Kawada
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Antibiograms and randomly amplified polymorphic DNA-polymerase chain reactions (RAPD-PCR) as epidemiological markers of gonorrhea.

Authors:  Ratana Lawung; Angkana Charoenwatanachokchai; Rungrot Cherdtrakulkiat; Sivarak Thammapiwan; Tharinda Mungniponpan; Leif Bülow; Virapong Prachayasittikul
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Authors:  C A Ison; P J Woodford; H Madders; E Claydon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Comparison of mismatch amplification mutation assay with DNA sequencing for characterization of fluoroquinolone resistance in Neisseria gonorrhoeae.

Authors:  Zafar Sultan; Shamsun Nahar; Bengt Wretlind; Emma Lindback; Motiur Rahman
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.